Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04040387 · ClinicalTrials.gov registry record · NA
NightWare Randomized Trial 02
A NA study, sponsored by NightWare.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
NCT04040387 is a NA study that has completed, run by NightWare. The registered enrollment target is 270 participants.
The verdict
NCT04040387, a NA study, has completed, sponsored by NightWare.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
Study Summary
This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with the NightWare digital therapeutic system. The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related nightmares and poor sleep quality.
Interventions
- DEVICE Sham NightWare
- DEVICE NightWare Therapeutic System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2019-07-24 |
| Est. Completion | 2025-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04040387
The ClinicalTrials.gov registry entry for NCT04040387 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NightWare, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham NightWare is the first listed.
NCT04040387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04040387 about?
NCT04040387 is a clinical study titled "NightWare Randomized Trial 02". This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of ...
What is the current status of trial NCT04040387?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2019-07-24. Estimated completion is 2025-08-02.
What interventions are being tested in trial NCT04040387?
The interventions under investigation include: Sham NightWare (DEVICE), NightWare Therapeutic System (DEVICE).
Who is sponsoring clinical trial NCT04040387?
This trial is sponsored by NightWare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.